196 related articles for article (PubMed ID: 10716235)
21. Effect of ketamine on hypoxic-ischemic brain damage in newborn rats.
Spandou E; Karkavelas G; Soubasi V; Avgovstides-Savvopoulou P; Loizidis T; Guiba-Tziampiri O
Brain Res; 1999 Feb; 819(1-2):1-7. PubMed ID: 10082854
[TBL] [Abstract][Full Text] [Related]
22. The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268.
Imre G
CNS Drug Rev; 2007; 13(4):444-64. PubMed ID: 18078428
[TBL] [Abstract][Full Text] [Related]
23. Metabotropic glutamate receptor 3 activation prevents nitric oxide-induced death in cultured rat astrocytes.
Durand D; Caruso C; Carniglia L; Lasaga M
J Neurochem; 2010 Jan; 112(2):420-33. PubMed ID: 20085613
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological stimulation of group ii metabotropic glutamate receptors reduces cocaine self-administration and cocaine-induced reinstatement of drug seeking in squirrel monkeys.
Adewale AS; Platt DM; Spealman RD
J Pharmacol Exp Ther; 2006 Aug; 318(2):922-31. PubMed ID: 16675638
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD
J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786
[TBL] [Abstract][Full Text] [Related]
26. The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving rat.
Cartmell J; Perry KW; Salhoff CR; Monn JA; Schoepp DD
J Neurochem; 2000 Sep; 75(3):1147-54. PubMed ID: 10936197
[TBL] [Abstract][Full Text] [Related]
27. Neuroprotective effects of selective group II mGluR activation in brain trauma and traumatic neuronal injury.
Movsesyan VA; Faden AI
J Neurotrauma; 2006 Feb; 23(2):117-27. PubMed ID: 16503796
[TBL] [Abstract][Full Text] [Related]
28. Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum.
Cartmell J; Salhoff CR; Perry KW; Monn JA; Schoepp DD
Brain Res; 2000 Dec; 887(2):378-84. PubMed ID: 11134627
[TBL] [Abstract][Full Text] [Related]
29. The activation of group II metabotropic glutamate receptors protects neonatal rat brains from oxidative stress injury after hypoxia-ischemia.
Bratek E; Ziembowicz A; Bronisz A; Salinska E
PLoS One; 2018; 13(7):e0200933. PubMed ID: 30044838
[TBL] [Abstract][Full Text] [Related]
30. Activation of mGlu1 but not mGlu5 metabotropic glutamate receptors contributes to postischemic neuronal injury in vitro and in vivo.
Meli E; Picca R; Attucci S; Cozzi A; Peruginelli F; Moroni F; Pellegrini-Giampietro DE
Pharmacol Biochem Behav; 2002 Sep; 73(2):439-46. PubMed ID: 12117599
[TBL] [Abstract][Full Text] [Related]
31. Interactions between the mGluR2/3 agonist, LY379268, and cocaine on in vivo neurochemistry and behavior in squirrel monkeys.
Bauzo RM; Kimmel HL; Howell LL
Pharmacol Biochem Behav; 2009 Nov; 94(1):204-10. PubMed ID: 19703487
[TBL] [Abstract][Full Text] [Related]
32. Neuroprotective effects of group II metabotropic glutamate receptor agonist DCG-IV on hippocampal neurons in transient forebrain ischemia.
Yoshioka H; Sugita M; Kinouchi H
Neurosci Lett; 2009 Sep; 461(3):266-70. PubMed ID: 19549561
[TBL] [Abstract][Full Text] [Related]
33. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
Cartmell J; Monn JA; Schoepp DD
J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900
[TBL] [Abstract][Full Text] [Related]
34. Effects of the mGlu2/3 receptor agonist LY379268 on motor activity in phencyclidine-sensitized rats.
Clark M; Johnson BG; Wright RA; Monn JA; Schoepp DD
Pharmacol Biochem Behav; 2002 Sep; 73(2):339-46. PubMed ID: 12117588
[TBL] [Abstract][Full Text] [Related]
35. Analgesic effects of the selective group II (mGlu2/3) metabotropic glutamate receptor agonists LY379268 and LY389795 in persistent and inflammatory pain models after acute and repeated dosing.
Jones CK; Eberle EL; Peters SC; Monn JA; Shannon HE
Neuropharmacology; 2005; 49 Suppl 1():206-18. PubMed ID: 15998527
[TBL] [Abstract][Full Text] [Related]
36. mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia.
Engel M; Snikeris P; Matosin N; Newell KA; Huang XF; Frank E
Psychopharmacology (Berl); 2016 Apr; 233(8):1349-59. PubMed ID: 26861891
[TBL] [Abstract][Full Text] [Related]
37. The mGlu(2/3) receptor agonist LY379268 selectively blocks amphetamine ambulations and rearing.
Cartmell J; Monn JA; Schoepp DD
Eur J Pharmacol; 2000 Jul; 400(2-3):221-4. PubMed ID: 10988337
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective effects of inter-alpha inhibitor proteins after hypoxic-ischemic brain injury in neonatal rats.
Chen X; Nakada S; Donahue JE; Chen RH; Tucker R; Qiu J; Lim YP; Stopa EG; Stonestreet BS
Exp Neurol; 2019 Jul; 317():244-259. PubMed ID: 30914159
[TBL] [Abstract][Full Text] [Related]
39. Anti-epileptic activity of group II metabotropic glutamate receptor agonists (--)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268) and (--)-2-thia-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY389795).
Moldrich RX; Jeffrey M; Talebi A; Beart PM; Chapman AG; Meldrum BS
Neuropharmacology; 2001 Jul; 41(1):8-18. PubMed ID: 11445181
[TBL] [Abstract][Full Text] [Related]
40. Activation of metabotropic glutamate (mGlu)2 receptors suppresses histamine release in limbic brain regions following acute ketamine challenge.
Fell MJ; Katner JS; Johnson BG; Khilevich A; Schkeryantz JM; Perry KW; Svensson KA
Neuropharmacology; 2010 Mar; 58(3):632-9. PubMed ID: 19951716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
